薏苡仁食疗对腹膜透析患者营养状况影响的研究

注册号:

Registration number:

ChiCTR-ONRC-12002552 

最近更新日期:

Date of Last Refreshed on:

2015-10-29 10:39:44 

注册时间:

Date of Registration:

2012-09-25 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

薏苡仁食疗对腹膜透析患者营养状况影响的研究

Public title:

The Effect of Coix Seed Diet on the Nutrion Status of Peritoneal Dialysis Patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

薏苡仁食疗对腹膜透析患者营养状况影响的研究

Scientific title:

The Effect of Coix Seed Diet on the Nutrion Status of Peritoneal Dialysis Patients

研究课题代号(代码):

Study subject ID:

广东省科技计划项目2010B030700062

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

吴一帆 

研究负责人:

刘旭生 

Applicant:

Wu Yifan 

Study leader:

Liu Xusheng 

申请注册联系人电话:

Applicant telephone:

+86 13560324448

研究负责人电话:

Study leader's
telephone:

+86 13503078703

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wuyifan007@163.com

研究负责人电子邮件:

Study leader's E-mail:

liuxu801@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市大德路111号肾病科

研究负责人通讯地址:

广东省广州市大德路111号肾病科

Applicant address:

111 Dade Road, Guangzhou, Guangdong

Study leader's address:

111 Dade Road, Guangzhou, Guangdong

申请注册联系人邮政编码:

Applicant postcode:

510120

研究负责人邮政编码:

Study leader's postcode:

510120

申请人所在单位:

广东省中医院

Applicant's institution:

Guangdong Provincial Hospital of Traditional Chinese Medicine

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

B2012-52-01

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

广东省中医院伦理委员会

Name of the ethic committee:

Institutional Ethics Committee of Guangdong Provincial Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2012-08-10 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广东省中医院肾病科

Primary sponsor:

Nephrology of of Guangdong Provincial Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

广东省广州市大德路111号肾病科

Primary sponsor's address:

111 Dade Road, Guangzhou, Guangdong

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

广州市

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东省中医院

具体地址:

广东省广州市大德路111号肾病科

Institution
hospital:

Guangdong Provincial Hospital of Traditional Chinese Medicine

Address:

111 Dade Road, Guangzhou, Guangdong

经费或物资来源:

广东省科技计划项目(2010B030700062)经费

Source(s) of funding:

Guangdong science and technology projects(2010B030700062) funding

研究疾病:

腹膜透析  

Target disease:

Peritoneal dialysis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

初步观察薏苡仁食疗对腹膜透析患者营养状态的干预效果,并探讨其可能的作用机理。  

Objectives of Study:

To determin the Effect of Coix Seed Diet on the Nutrion Status of Peritoneal Dialysis Patients

药物成份或治疗方案详述:

薏苡仁 

Description for medicine or protocol of treatment in detail:

coix seed 

纳入标准:

Inclusion criteria

排除标准:

(1)有严重心律失常或3个月内有急性心衰、心肌梗死、急性脑卒中、不稳定性心绞痛等急性并发症者。
(2)3个月内合并有急性感染性疾病、活动期恶性肿瘤、肝硬化失代偿期等可能影响患者营养状态的疾病。
(3)有精神疾病或因其它原因不能配合治疗、调查者。
(4)对薏苡仁过敏者。

Exclusion criteria:

(1) With severe arrhythmia or acute complications in the past three months, including acute heart failuremyocardial infarctionacute stroke,unstable angina pectoris,etc.;
(2) With wasting disease in the past 3 months, including acute inflammation, active stage malignancy, decompensated liver cirrhosis;
(3) With mental disease or other reasons unable to coorperate treatment and survey;
(4) Allergic to coix seed.

研究实施时间:

Study execute time:

From 2011-09-01 00:00:00 To 2012-03-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2011-06-01 00:00:00 To 1990-01-01 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

15

Group:

control group

Sample size:

干预措施:

常规治疗

干预措施代码:

Intervention:

conventional treatment

Intervention code:

组别:

薏米组

样本量:

15

Group:

coix seed group

Sample size:

干预措施:

常规治疗+薏苡仁

干预措施代码:

Intervention:

conventional treatment + coix seed

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

广州 

Country:

China

Province:

Guangdong

City:

Guangzhou

单位(医院):

广东省中医院 

单位级别:

三甲医院 

Institution
hospital:

Guangdong Provincial Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A hospital

测量指标:

Outcomes:

指标中文名:

白蛋白

指标类型:

主要指标

Outcome:

Albumin

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

上臂围

指标类型:

次要指标

Outcome:

upper-arm circumference

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

上臂肌围

指标类型:

次要指标

Outcome:

arm muscle circumference

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重指数

指标类型:

次要指标

Outcome:

body mass index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

总蛋白

指标类型:

次要指标

Outcome:

total protein

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血红蛋白

指标类型:

次要指标

Outcome:

hemoglobin

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

C反应蛋白

指标类型:

次要指标

Outcome:

C-reactive protein

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血钾

指标类型:

次要指标

Outcome:

serum kalium

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血钠

指标类型:

次要指标

Outcome:

serum sodium

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血钙

指标类型:

次要指标

Outcome:

serum calcium

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血磷

指标类型:

次要指标

Outcome:

serum phosphate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

甲状旁腺激素

指标类型:

次要指标

Outcome:

parathyroid hormone

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

主观综合营养评估分级

指标类型:

次要指标

Outcome:

classification of subjective global assessment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中医症状评分

指标类型:

次要指标

Outcome:

the symptomatic score of TC

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

透析液

组织:

腹腔

Sample Name:

dislysate

Tissue:

abdominal cavity

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

静脉血

组织:

静脉

Sample Name:

venous blood

Tissue:

vein

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

尿液

组织:

膀胱

Sample Name:

bladder

Tissue:

bladder

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 80 years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

非随机:根据患者意愿分组

Randomization Procedure (please state who generates the random number sequence and by what method):

non randomized control:with patient`s will

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

数据与安全监察委员会:

Data and Safety Monitoring Committee:

注册人:

Name of Registration:

 2012-10-09 00:00:00